In 2013, Mary Lou Polo was given just a week to live. She had stage IV ovarian cancer, and her chances of survival were grim. This September, more than 10 years later, Polo recently celebrated her ...

Adding bevacizumab to the combination therapy of carboplatin and paclitaxel significantly improved progression-free survival (PFS) in patients with epithelial ovarian cancer (EOC) but not overall ...

Late-stage ovarian cancer presents one of the most daunting challenges within oncology. Given the limited treatment options, patients and healthcare providers often find themselves navigating a ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — In this video, Susana M. Campos, MD, MPH, discusses results from a phase 3 clinical trial of ...